 |
ARIZONA STATE SENATE
Fifty-Fourth Legislature, First Regular Session
nonprescription drug permits; repeal
Purpose
Removes the requirement that a person obtain a permit from the Board of Pharmacy (Board) to sell, retail, stock, expose or offer nonprescription drugs.
Background
The Board regulates the practice of pharmacy and the distribution, sale and storage of prescription medications, prescriptive devices and nonprescription medications. The Board is charged with licensing pharmacists, pharmacy interns, pharmacy technicians and pharmacy technician trainees, and issues permits to pharmacies, drug manufacturers, wholesalers, distributors and suppliers in Arizona. A nonprescription drug is any nonnarcotic medicine or drug that can be sold without a prescription and that is prepackaged and labeled for use by the consumer in accordance with state and federal law (A.R.S. § 32-1901).
Currently, statute permits the Board to issue an applicant a nonprescription drug permit to sell, retail, stock, expose or offer for sale, at retail, nonprescription drugs. The biennial permit fee for a nonprescription drug permit is $120 for category I retailers and $200 for category II retailers. Additionally, the Board is authorized to issue a nonprescription drug wholesale permit that has a biennial fee of $500 (A.R.S. §§ 32-1931 and 32-1930).
There is no anticipated fiscal impact to the state General Fund associated with this legislation.
Provisions
1. Eliminates the requirement that a person apply to the Board for a nonprescription drug permit to sell, retail, stock, expose or offer for sale, at retail, nonprescription drugs.
2. Removes the biennial permit fees for nonprescription drug permits.
3. Makes technical and conforming changes.
4. Becomes effective on the general effective date.
Prepared by Senate Research
February 13, 2019
CRS/AB/kja